Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ik Shin Chin
Observed names:
Chin, Ik Shin,
I.S. Chin,
IS Chin,
Ik S. Chin
Institution:
Clatterbridge Cancer Centre NHS Foundation Trust
Observed institutions:
University Hospitals Birmingham NHS Foundation Trust,
University Hospital Coventry,
University Hospitals Coventry and Warwickshire NHS Trust,
Clatterbridge Cancer Centre NHS Foundation Trust,
University of Birmingham
ORCID:
0000-0002-7659-8753
Observed ORCID:
0000-0002-7659-8753
OpenAlex ID:
A5049575537
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19
2022
·
Csilla Várnai
, Claire Palles
, et al.
·
JAMA Network Open
·
62
PDF
Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity
2022
·
Ik Shin Chin
, Aman Khan
, et al.
·
npj Genomic Medicine
·
39
PDF
Factors Affecting Medical Students’ Uptake of the 2009 Pandemic Influenza A (H1N1) Vaccine
2012
·
Siang I. Lee
, Ei M. Aung
, et al.
·
Influenza Research and Treatment
·
22
PDF
Influence of clinical characteristics and anti-cancer therapy on outcomes from SARS-CoV-2 infection: a systematic review and meta-analysis of 5,678 cancer patients
2020
·
Ik Shin Chin
, Sara Galavotti
, et al.
·
medRxiv
·
6
PDF
A phase 1/2 study of the next-generation nectin-4–targeting antibody-drug conjugate CRB-701 (SYS6002) in patients with recurrent or metastatic head and neck squamous cell carcinoma.
2026
·
Charlene Mantia
, Glenn J. Hanna
, et al.
·
Journal of Clinical Oncology
·
1
Developments in Immunotherapy
2025
·
Kyrillus Shohdy
, Ik Shin Chin
, et al.
·
CRC Press eBooks
·
1
S7 Impact of frailty and comorbidities on treatment decisions and outcomes in patients with lung cancer: a retrospective cohort study
2024
·
KP Yip
, HK Dhillon
, et al.
·
Thorax
161P Early phase cancer clinical trials: A viable treatment option for patients?
2024
·
R.C. Dawson
, R. Yan
, et al.
·
ESMO Open
Will it be possible to find predictive genetic markers of immune checkpoint inhibitor toxicity that are not also predictive of survival?
2024
·
Claire Palles
, Ik Shin Chin
·
Immuno Oncology Insights
2240P Novel genetic markers associated with immune checkpoint inhibitor induced immune-related adverse events
2023
·
I.S. Chin
, L. Mcdonald
, et al.
·
Annals of Oncology
PDF
A novel genetic marker of fluoropyrimidine-induced cardiovascular toxicity.
2023
·
Claire Palles
, Marie Lucas
, et al.
·
Journal of Clinical Oncology
PDF
1768P Genome-wide association study to identify genetic markers predictive of early-onset capecitabine-induced toxicity
2021
·
I.S. Chin
, D. Church
, et al.
·
Annals of Oncology
Clinical presentation and prognosis of high PD-L1 expressors in non-small cell lung cancer
2019
·
I.S. Chin
, K.P. Yip
, et al.
·
Lung Cancer
114: Management and outcomes of large cell neuroendocrine lung cancer
2017
·
L. McAvan
, I.S. Chin
, et al.
·
Lung Cancer
Show more works
View as search
Works count:
15
Citation count:
131
H-index:
4
I10-index:
3
Year
Topic
Type